Related Experiment Videos
Melampomagnolide B: a new antileukemic sesquiterpene
Shama Nasim1, ShanShan Pei, Fred K Hagen
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
Bioorganic & Medicinal Chemistry
|January 29, 2011
Summary
Melampomagnolide B, a novel sesquiterpene, shows promise as an antileukemic agent. Its targeted action against leukemia cells stems from exploiting specific biochemical differences, sparing normal cells.
Area of Science:
- Natural Product Chemistry
- Cancer Biology
- Biochemistry
Background:
- Melampomagnolide B is a newly identified sesquiterpene with potential antileukemic properties.
- Understanding its mechanism of action is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the mechanism of action of melampomagnolide B.
- To investigate the biochemical basis for its selective toxicity towards leukemic cells.
Main Methods:
- Synthesis of a biotin-conjugated derivative of melampomagnolide B.
- Study of biochemical interactions of the biotin probe.
Main Results:
- The biotin probe facilitated the study of melampomagnolide B's interactions.
- Evidence suggests melampomagnolide B exploits biochemical disparities between cell types.
Conclusions:
- Melampomagnolide B exhibits selective antileukemic activity.
- The compound's efficacy is linked to its ability to target unique biochemical features of leukemic cells over normal hematopoietic cells.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...